95 related articles for article (PubMed ID: 7875201)
21. Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12.
Naume B; Johnsen AC; Espevik T; Sundan A
Eur J Immunol; 1993 Aug; 23(8):1831-8. PubMed ID: 7688307
[TBL] [Abstract][Full Text] [Related]
22. IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.
Rahaman SO; Sharma P; Harbor PC; Aman MJ; Vogelbaum MA; Haque SJ
Cancer Res; 2002 Feb; 62(4):1103-9. PubMed ID: 11861389
[TBL] [Abstract][Full Text] [Related]
23. Evidence for a critical role for the cytoplasmic region of the interleukin 2 (IL-2) receptor gamma chain in IL-2, IL-4, and IL-7 signalling.
Kawahara A; Minami Y; Taniguchi T
Mol Cell Biol; 1994 Aug; 14(8):5433-40. PubMed ID: 8035820
[TBL] [Abstract][Full Text] [Related]
24. Expression of the murine interleukin 6 receptor in hepatoma cells: the intracytoplasmic domain is not required for interleukin 6 signal transduction.
Fiorillo MT; Toniatti C; Van Snick J; Ciliberto G
Eur J Immunol; 1992 Mar; 22(3):799-804. PubMed ID: 1312474
[TBL] [Abstract][Full Text] [Related]
25. [Molecular aspects of IL-7-IL-7 receptor system].
Sudo T
Nihon Rinsho; 1992 Aug; 50(8):1811-5. PubMed ID: 1433972
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of interleukin 7 receptor signaling by antigen receptor assembly.
Smart FM; Venkitaraman AR
J Exp Med; 2000 Feb; 191(4):737-42. PubMed ID: 10684865
[TBL] [Abstract][Full Text] [Related]
27. Shared gamma(c) subunit within the human interleukin-7 receptor complex. A molecular basis for the pathogenesis of X-linked severe combined immunodeficiency.
Lai SY; Molden J; Goldsmith MA
J Clin Invest; 1997 Jan; 99(2):169-77. PubMed ID: 9005984
[TBL] [Abstract][Full Text] [Related]
28. IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor alpha chain.
Wang HY; Paul WE; Keegan AD
Immunity; 1996 Feb; 4(2):113-21. PubMed ID: 8624802
[TBL] [Abstract][Full Text] [Related]
29. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice.
Peschon JJ; Morrissey PJ; Grabstein KH; Ramsdell FJ; Maraskovsky E; Gliniak BC; Park LS; Ziegler SF; Williams DE; Ware CB; Meyer JD; Davison BL
J Exp Med; 1994 Nov; 180(5):1955-60. PubMed ID: 7964471
[TBL] [Abstract][Full Text] [Related]
30. Absence of the IL-7 receptor component CDw127 indicates that gamma(c) expression alone is insufficient for IL-7 to modulate human neutrophil responses.
Girard D; Beaulieu AD
Clin Immunol Immunopathol; 1997 Jun; 83(3):264-71. PubMed ID: 9175915
[TBL] [Abstract][Full Text] [Related]
31. Reconstitution of the functional interleukin-5 receptor: the cytoplasmic domain of alpha-subunit plays an important role in growth signal transduction.
Takaki S; Takatsu K
Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):36-8. PubMed ID: 8156002
[TBL] [Abstract][Full Text] [Related]
32. Homology modeling study of the human interleukin-7 receptor complex.
Kroemer RT; Richards WG
Protein Eng; 1996 Dec; 9(12):1135-42. PubMed ID: 9010926
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin-1 function.
Re F; Sironi M; Muzio M; Matteucci C; Introna M; Orlando S; Penton-Rol G; Dower SK; Sims JE; Colotta F; Mantovani A
J Exp Med; 1996 Apr; 183(4):1841-50. PubMed ID: 8666940
[TBL] [Abstract][Full Text] [Related]
34. [Interleukin-6 (IL-6) receptor].
Sakamoto K; Ogawa M; Sakamoto K
Nihon Rinsho; 1997 Apr; 55 Suppl 2():538-41. PubMed ID: 9172585
[No Abstract] [Full Text] [Related]
35. A novel IL-10 signalling mechanism regulates TIMP-1 expression in human prostate tumour cells.
Wang M; Hu Y; Stearns ME
Br J Cancer; 2003 May; 88(10):1605-14. PubMed ID: 12771930
[TBL] [Abstract][Full Text] [Related]
36. Growth inhibitory and agonistic signals of interleukin-7 (IL-7) can be mediated through the CDw127 IL-7 receptor.
Pandrau-Garcia D; de Saint-Vis B; Saeland S; Renard N; Ho S; Moreau I; Banchereau J; Galizzi JP
Blood; 1994 Jun; 83(12):3613-9. PubMed ID: 8204885
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-7 and lymphopoiesis: biological and clinical implications.
Appasamy PM
Cancer Treat Res; 1995; 80():235-60. PubMed ID: 8821580
[No Abstract] [Full Text] [Related]
38. Therapeutic approaches to chronic intestinal inflammation by specific targeting of mucosal IL-7/IL-7R signal pathway.
Watanabe M; Yamazaki M; Okamoto R; Ohoka S; Araki A; Nakamura T; Kanai T
Curr Drug Targets Inflamm Allergy; 2003 Jun; 2(2):119-23. PubMed ID: 14561163
[TBL] [Abstract][Full Text] [Related]
39. IL-7 and IL-7R in health and disease: An update through COVID times.
Fernandes MB; Barata JT
Adv Biol Regul; 2023 Jan; 87():100940. PubMed ID: 36503870
[TBL] [Abstract][Full Text] [Related]
40. Expression and functional reconstitution of IL-18 receptor in K562 leukemia cells.
Zhang B; Cao ZY; Wu KF; Lin YM
Leuk Res; 2003 Oct; 27(10):971-2. PubMed ID: 12860020
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
